Masimo Corporation $MASI Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC lowered its stake in Masimo Corporation (NASDAQ:MASI) by 6.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 583,747 shares of the medical equipment provider’s stock after selling 37,185 shares during the quarter. Squarepoint Ops LLC’s holdings in Masimo were worth $75,922,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC purchased a new position in shares of Masimo in the 4th quarter valued at about $27,000. Los Angeles Capital Management LLC purchased a new position in Masimo during the 4th quarter worth approximately $31,000. Rothschild Investment LLC grew its stake in Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 259 shares during the last quarter. Torren Management LLC purchased a new position in Masimo during the 4th quarter worth approximately $35,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Masimo during the 4th quarter worth approximately $38,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

Masimo stock opened at $179.95 on Tuesday. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.99. The stock has a 50 day moving average of $178.72 and a two-hundred day moving average of $160.89. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11.

Analysts Set New Price Targets

A number of research analysts recently issued reports on MASI shares. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Stifel Nicolaus set a $180.00 price target on Masimo in a research note on Tuesday, February 17th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research note on Tuesday, February 17th. Finally, Wells Fargo & Company upgraded Masimo to a “hold” rating in a research note on Wednesday, March 18th. Nine equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.